Patents Assigned to U.D. Testing, Inc.
  • Patent number: 5955370
    Abstract: A test method for determining adulteration by diuresis or the addition of a diuretic, which uses creatinine and specific gravity measurements to determine a normalized creatinine value for comparison with expected normalized creatinine values for the substantially diuretic-free population.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: September 21, 1999
    Assignee: U.D. Testing, Inc.
    Inventor: Michael Kell
  • Patent number: 5908788
    Abstract: A method of monitoring compliance of a patient that has been placed on a medication maintenance program with a prescribed medication dosage by determining a normalized urine methadone concentration. An unadulterated urine sample is obtained from the patient. The urine methadone concentration and urine specific gravity are measured. The normalized urine medication concentration is calculated as a function of the measured medication concentration in the urine and the urine specific gravity. The calculated normalized urine medication concentration is compared with an expected medication concentration value for the patient for the maintenance program prescribed to determine any significant differences therebetween as an indication of noncompliance. Alternatively, a urinary-parameter normalized urine medication concentration is calculated as a function of the measured medication concentration in the urine, the urine specific gravity and at least one selected pharmacokinetic parameter of the medication.
    Type: Grant
    Filed: August 19, 1996
    Date of Patent: June 1, 1999
    Assignee: U.D. Testing, Inc.
    Inventor: Michael Kell